Identification of valepotriate as a novel antimycobacterial agent against drug-resistant Mycobacterium tuberculosis through screening of a natural terpenoid compound library
JAC-Antimicrobial Resistance · 31.10.2026 · 8 (6)
DOI: 10.1093/jacamr/dlag250 ↗Kurz gefasst
Fachartikel in der Zeitschrift JAC-Antimicrobial Resistance, online erschienen am 10.11.2026. Verfasst von Chuanzhi Zhu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Beijing Key Laboratory for Drug Resistant Tuberculosis Research, Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing Chest Hospital, …. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Beijing Natural Science Foundation, Prevention and Control of Emerging and Major Infectious Disease-National Science and Technology Major Project, National Natural Science Foundation.
Abstract (Originalsprache)
Background
The continued emergence of multidrug-resistant Mycobacterium tuberculosis (M. tb) has substantially limited treatment options and highlights the need for new antimycobacterial agents. Although terpenoids comprise one of the largest classes of natural products with diverse biological activities, their antimycobacterial potential has not been systematically investigated.
Methods
A library comprising 354 natural terpenoid compounds were screened against M. tb. Lead compounds were subsequently characterized by determining minimum inhibitory concentrations (MICs), minimum bactericidal concentrations (MBCs), time–kill kinetics, activity against clinical drug-sensitive and drug-resistant isolates, cytotoxicity in THP-1–derived macrophages and intracellular antimycobacterial activity using colony-forming unit assays.
Results
Primary screening identified 10 compounds with strong antimycobacterial activity, among which valepotriate showed as a novel antimycobacterial agent. Valepotriate inhibited extracellular M. tb growth with an MIC of 10 μM and an MBC of 20 μM. Time–kill assays demonstrated rapid concentration-dependent bactericidal activity, reducing bacterial counts by >2 log10 cfu within 24 h at 4× MIC and completely eradicating viable bacteria within 24 h at 8× and 16× MIC. Valepotriate retained activity against 14 clinical drug-sensitive and drug-resistant isolates with MIC values ranging from 5 to 20 μM. Valepotriate significantly reduced the intracellular bacterial burden at bactericidal concentrations that were well tolerated by THP-1–derived macrophages.
Conclusions
Systematic screening identified valepotriate as a rapidly bactericidal antimycobacterial lead compound with activity against both drug-susceptible and drug-resistant M. tb, highlighting its potential as a natural product-derived scaffold for developing new antimycobacterial agents and motivating further optimization of its antibacterial potency.
Autor:innen und Institutionen
- Beijing Key Laboratory for Drug Resistant Tuberculosis Research, Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing Chest Hospital, Capital Medical University, Beijing 101149, China.
ORCID-Profile: Chuanzhi Zhu, Zongde Zhang
Förderung
- Beijing Natural Science Foundation
- Prevention and Control of Emerging and Major Infectious Disease-National Science and Technology Major Project
- National Natural Science Foundation
- Beijing High-level Public Health Project
Zitieren
APA
Zhu, C., Wang, X., Zhang, X., Jia, H., Zhang, L., Zhang, Z., & Pan, L. (2026). Identification of valepotriate as a novel antimycobacterial agent against drug-resistant Mycobacterium tuberculosis through screening of a natural terpenoid compound library. JAC-Antimicrobial Resistance, 8(6). https://doi.org/10.1093/jacamr/dlag250
Vancouver
Zhu C, Wang X, Zhang X, Jia H, Zhang L, Zhang Z, et al. Identification of valepotriate as a novel antimycobacterial agent against drug-resistant Mycobacterium tuberculosis through screening of a natural terpenoid compound library. JAC-Antimicrobial Resistance. 2026;8(6). doi:10.1093/jacamr/dlag250
BibTeX
@article{Zhu2026,
author = {Zhu, Chuanzhi and Wang, Xinyu and Zhang, Xinyue and Jia, Hongyan and Zhang, Lanyue and Zhang, Zongde and Pan, Liping},
title = {Identification of valepotriate as a novel antimycobacterial agent against drug-resistant Mycobacterium tuberculosis through screening of a natural terpenoid compound library},
journal = {JAC-Antimicrobial Resistance},
year = {2026},
volume = {8},
number = {6},
doi = {10.1093/jacamr/dlag250}
}
EUVIMED